Literature DB >> 18617626

Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise.

Paul D Chantler1, Edward G Lakatta, Samer S Najjar.   

Abstract

Understanding the performance of the left ventricle (LV) requires not only examining the properties of the LV itself, but also investigating the modulating effects of the arterial system on left ventricular performance. The interaction of the LV with the arterial system, termed arterial-ventricular coupling (E(A)/E(LV)), is a central determinant of cardiovascular performance and cardiac energetics. E(A)/E(LV) can be indexed by the ratio of effective arterial elastance (E(A); a measure of the net arterial load exerted on the left ventricle) to left ventricular end-systolic elastance (E(LV); a load-independent measure of left ventricular chamber performance). At rest, in healthy individuals, E(A)/E(LV) is maintained within a narrow range, which allows the cardiovascular system to optimize energetic efficiency at the expense of mechanical efficacy. During exercise, an acute mismatch between the arterial and ventricular systems occurs, due to a disproportionate increase in E(LV) (from an average of 4.3 to 13.2, and 4.7 to 15.5 mmHg.ml(-1).m(-2) in men and women, respectively) vs. E(A) (from an average of 2.3 to 3.2, and 2.3 to 2.9 mmHg.ml(-1).m(-2) in men and women, respectively), to ensure that sufficient cardiac performance is achieved to meet the increased energetic requirements of the body. As a result E(A)/E(LV) decreases from an average of 0.58 to 0.34, and 0.52 to 0.27 in men and women, respectively. In this review, we provide an overview of the concept of E(A)/E(LV), and examine the effects of age, hypertension, and heart failure on E(A)/E(LV) and its components (E(A) and E(LV)) in men and women. We discuss these effects both at rest and during exercise and highlight the mechanistic insights that can be derived from studying E(A)/E(LV).

Entities:  

Mesh:

Year:  2008        PMID: 18617626      PMCID: PMC2576043          DOI: 10.1152/japplphysiol.90600.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  81 in total

1.  Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.

Authors:  Vojtech Melenovsky; Barry A Borlaug; Boaz Rosen; Ilan Hay; Luigi Ferruci; Christopher H Morell; Edward G Lakatta; Samer S Najjar; David A Kass
Journal:  J Am Coll Cardiol       Date:  2006-12-29       Impact factor: 24.094

Review 2.  Scaling, normalizing, and per ratio standards: an allometric modeling approach.

Authors:  A M Nevill; R L Holder
Journal:  J Appl Physiol (1985)       Date:  1995-09

3.  Relationship of effective arterial elastance to demographic and arterial characteristics in normotensive and hypertensive adults.

Authors:  P S Saba; M J Roman; A Ganau; R Pini; E C Jones; T G Pickering; R B Devereux
Journal:  J Hypertens       Date:  1995-09       Impact factor: 4.844

4.  Optimal coupling of the left ventricle with the arterial system.

Authors:  K Sunagawa; M Sugimachi; K Todaka; T Kobota; K Hayashida; R Itaya; A Chishaki; A Takeshita
Journal:  Basic Res Cardiol       Date:  1993       Impact factor: 17.165

5.  Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota.

Authors:  Carolyn S P Lam; Véronique L Roger; Richard J Rodeheffer; Francesca Bursi; Barry A Borlaug; Steve R Ommen; David A Kass; Margaret M Redfield
Journal:  Circulation       Date:  2007-04-02       Impact factor: 29.690

6.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

7.  Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Stuart D Russell; Kristy Kessler; Karel Pacak; Lewis C Becker; David A Kass
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

8.  Effect of exercise on left ventricular-arterial coupling assessed in the pressure-volume plane.

Authors:  W C Little; C P Cheng
Journal:  Am J Physiol       Date:  1993-05

9.  Left ventricular-arterial coupling in systemic hypertension: analysis by means of arterial effective and left ventricular elastances.

Authors:  A Cohen-Solal; B Caviezel; D Himbert; R Gourgon
Journal:  J Hypertens       Date:  1994-05       Impact factor: 4.844

10.  Gender differences and aging: effects on the human heart.

Authors:  G Olivetti; G Giordano; D Corradi; M Melissari; C Lagrasta; S R Gambert; P Anversa
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

View more
  89 in total

Review 1.  Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.

Authors:  Kenneth R Boheler
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  Evaluation of carotid wave intensity in firefighters following firefighting.

Authors:  Huimin Yan; Christopher A Fahs; Sushant Ranadive; Lindy M Rossow; Abbi D Lane; Stamatis Agiovlasitis; George Echols; Denise Smith; Gavin P Horn; Thomas Rowland; Bo Fernhall
Journal:  Eur J Appl Physiol       Date:  2011-10-29       Impact factor: 3.078

3.  Effect of exercise training on biologic vascular age in healthy seniors.

Authors:  Shigeki Shibata; Benjamin D Levine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

4.  Use of the Frank-Starling mechanism during exercise is linked to exercise-induced changes in arterial load.

Authors:  Paul D Chantler; Vojtech Melenovsky; Steven P Schulman; Gary Gerstenblith; Lewis C Becker; Luigi Ferrucci; Jerome L Fleg; Edward G Lakatta; Samer S Najjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

5.  Validity of predicting left ventricular end systolic pressure changes following an acute bout of exercise.

Authors:  Rebecca M Kappus; Sushant M Ranadive; Huimin Yan; Abbi D Lane; Marc D Cook; Grenita Hall; I Shevon Harvey; Kenneth R Wilund; Jeffrey A Woods; Bo Fernhall
Journal:  J Sci Med Sport       Date:  2012-06-20       Impact factor: 4.319

6.  Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.

Authors:  Michal Schäfer; Cynthia Myers; R Dale Brown; Maria G Frid; Wei Tan; Kendall Hunter; Kurt R Stenmark
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

7.  Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.

Authors:  Leo F Buckley; Salvatore Carbone; Cory R Trankle; Justin M Canada; Claudia Oddi Erdle; Jessica A Regan; Michele M Viscusi; Dinesh Kadariya; Hayley Billingsley; Ross Arena; Antonio Abbate; Benjamin W Van Tassell
Journal:  J Cardiovasc Pharmacol       Date:  2018-07       Impact factor: 3.105

8.  Apparent Aortic Stiffness in Children With Pulmonary Arterial Hypertension: Existence of Vascular Interdependency?

Authors:  Michal Schäfer; D Dunbar Ivy; Steven H Abman; Alex J Barker; Lorna P Browne; Brian Fonseca; Vitaly Kheyfets; Kendall S Hunter; Uyen Truong
Journal:  Circ Cardiovasc Imaging       Date:  2017-02       Impact factor: 7.792

Review 9.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-02-16       Impact factor: 4.132

10.  Inefficient Ventriculoarterial Coupling in Fontan Patients: A Cardiac Magnetic Resonance Study.

Authors:  Max E Godfrey; Rahul H Rathod; Ellen Keenan; Kimberlee Gauvreau; Andrew J Powell; Tal Geva; Ashwin Prakash
Journal:  Pediatr Cardiol       Date:  2018-02-05       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.